Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Retained Earnings (2023 - 2025)

Rallybio (RLYB) has disclosed Retained Earnings for 3 consecutive years, with -$302.0 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 444217.65% to -$302.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$302.0 million through Dec 2025, down 444217.65% year-over-year, with the annual reading at -$302.0 million for FY2025, 444217.65% down from the prior year.
  • Retained Earnings hit -$302.0 million in Q4 2025 for Rallybio, down from $24000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $169000.0 in Q3 2024 to a low of -$312.2 million in Q2 2025.
  • Historically, Retained Earnings has averaged -$105.1 million across 3 years, with a median of -$171500.0 in 2023.
  • Biggest five-year swings in Retained Earnings: soared 353.33% in 2024 and later crashed 444217.65% in 2025.
  • Year by year, Retained Earnings stood at $15000.0 in 2023, then skyrocketed by 353.33% to $68000.0 in 2024, then plummeted by 444217.65% to -$302.0 million in 2025.
  • Business Quant data shows Retained Earnings for RLYB at -$302.0 million in Q4 2025, $24000.0 in Q3 2025, and -$312.2 million in Q2 2025.